Clinical outcome and prognostic factors at baseline among patients included in a phase II trial: The SBP2 study.

e17713 Background: “Life expectancy > 12 weeks” is a frequent inclusion criterion in phase 2 study protocols despite its subjective nature. The aim of this study is to identify predictive factors o...